Sign in
Taking people in United StatesPhase 1

Tests a faster radiation planning method for pancreatic cancer abdominal pain

Tests faster radiation planning for abdominal pain in adults with pancreatic cancer.

Key facts

Who runs it
Case Comprehensive Cancer Center
Where
Cleveland, United StatesSee the site
Trial code
Registry title
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
Status
Recruiting
Phase
Phase 1
People taking part
5 people, planned
Started
12 May 2026
Expected to end
Feb 2027
Type of study
Interventional
Treatments tested
  • Simulation-free workflow
  • Celiac plexus SBRT
Record updated
22 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with metastatic or unresectable cancer, including pancreatic cancer, who have severe belly and back pain that involves the celiac plexus. It tests a faster way to plan radiation for the pain.

Age
Older than 18 years.
Sex
All sexes can join.
Disease stage
Confirmed cancer that is metastatic or cannot be removed by surgery. Severe belly-to-back pain of at least 5 on an 11-point pain scale despite pain medicine. The celiac plexus must be involved on a recent scan, as in any pancreatic cancer.
Earlier treatment
Earlier chemotherapy or biological treatment is allowed. Any active cancer treatment must stop at least 1 week before radiation and restart at least 1 week after. Earlier celiac plexus block is allowed. No earlier radiation to the upper abdomen.

Main reasons for not taking part

  • Earlier radiation to the upper abdomen
  • Pregnant or breastfeeding women
  • Conditions that raise the risk of radiation side effects, such as inflammatory bowel disease or scleroderma
  • No diagnostic CT, PET/CT or MRI of the abdomen and pelvis taken less than 28 days before consent

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Participants must have histologically or cytologically confirmed cancer that is metastatic or unresectable, and considered appropriate per the treating physician to receive celiac plexus SBRT
  • Age >18 years. Because no data are currently available on the use of celiac axis SBRT in participants ≤18 years of age, children are excluded from this study
  • Performance status: ECOG Performance status ≤ 3
  • Severe retroperitoneal pain syndrome (radiates from the lower back to the upper abdomen, belt- like distribution), intensity of at least 5 on 11-point Brief Pain Inventory (BPI, average pain) scale despite analgesic use. Note: previous use of celiac plexus block/neurolysis for pain control is allowed and will be recorded
  • Participants must have anatomical involvement of the celiac plexus on the diagnostic CT, PET/CT, or MRI. This includes:; Any pancreatic cancer; Any other cancer that on imaging demonstrates either gross involvement of the celiac blood vessels or celiac plexus on imaging OR haziness around the celiac blood vessels that typically implies tumor engulfment
  • Prior chemotherapy or biological treatment is allowed, but any active oncological treatment must be stopped at least 1 week prior to radiation therapy and renewed at least 1 week following radiation therapy
  • Participants must have the ability to understand and the willingness to sign a written informed consent document
  • Participants must have a diagnostic CT, PET/CT, or MRI of the abdomen and pelvis, with or without contrast, acquired < 28 days prior to the study consent. This diagnostic scan, to be used for pre-plan formation, must fully visualize the celiac plexus target intended for simulation-free treatment, with full axial field-of-view at the axial levels for treatment. The scan must be of sufficient clinical quality for the treating physician to delineate the target for treatment

Who cannot take part

  • Prior radiotherapy to the upper abdomen
  • Previous radiotherapy to the upper abdomen overlapping with the projected site of treatment
  • Participants with conditions associated with increased risk of side effects from radiation such as inflammatory bowel disease and scleroderma
  • Pregnant or breastfeeding women are excluded from this study
  • Women of childbearing potential must have a negative pregnancy test within 14 days of study entry. If pregnancy test is not clinically indicated as determined by treating physician or protocol principal investigator, documentation of this exception is sufficient in lieu of a pregnancy test

Where in United States

  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer CenterCleveland, United StatesContact: Lauren Henke, MD, MSCITaking people

About the trial

What the trial wants to find out

Participants who are experiencing abdominal pain due to having cancer in their pancreas may be eligible for this research study. For this type of pain, doctors often recommend radiation therapy to help with the pain. This radiation therapy is called stereotactic body radiotherapy (SBRT). Preparing for SBRT typically takes a week or longer. In this research study, doctors want to test a new workflow in order to shorten the time it takes for participants to receive SBRT to help with their pain.

Read full original descriptionShow less

Doctors typically determine how to administer the SBRT by doing a simulation, which requires a CT (Computerized Tomography) scan. The CT scan is used to create a treatment plan. It can take time to schedule this CT scan and then it takes 5-10 days to create a treatment plan. A way to reduce the planning time for SBRT is to use the CT scan that participants had when their cancer was diagnosed to plan the SBRT. This new workflow can cut down the time it takes to schedule another CT scan and plan for and deliver SBRT. The workflow where doctors use a pre-existing CT scan is called CTsim-free treatment planning. CTsim-free treatment planning is what is being tested in this research study.

The group in the trial

  • Simulation-free treatment delivery of celiac plexus SBRTTreatment being tested

    Treatment: Simulation-free workflow and Celiac plexus SBRT

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective Pilot Clinical Trial of Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
Plain-language title
Tests a faster radiation planning method for pancreatic cancer abdominal painGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
22 September 2026